(3R)-1'-[3-(3,4-Dihydro-1,5-naphthyridin-1(2H)-yl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-3H-spiro[1-benzofuran-2,4'-piperidin]-3-amine(CAS: 2377352-49-1)

This compound should be handled in compliance with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements for the transport and disposal of hazardous substances. Specific precautions include proper labeling, storage, and handling to avoid environmental contamination and ensure worker safety.

Alternatives to this compound can include other naphthyridine-pyrazolo-pyrazine derivatives or closely related spiro compounds. Common substitutes might involve different functional groups or simpler structures, which can be easier to synthesize and may have similar or complementary properties.

The market for this compound is currently driven by increasing research interest in its potential biological activities. Emerging trends include its use in developing new therapeutics, particularly in anti-inflammatory and anticancer applications. Further research is expected to explore its efficacy and safety in various clinical settings.

Waste containing this compound should be handled by professionals using appropriate safety equipment. Waste liquids should be collected in sealed containers and disposed of according to local hazardous waste regulations. Incineration or professional waste disposal services should be utilized to ensure environmental safety and compliance with regulatory standards.